Affini-T Therapeutics
Biotechnology company developing T-cell therapies for patients suffering from cancer. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD1.1—1.6b (Dealroom.co estimates Mar 2022.)
Boston Massachusetts (HQ)
Authorizing premium user...